Cargando…
COVD-20. COVID-19 INFECTION DURING CHEMOTHERAPY FOR MALIGNANT GLIOMA: OUTCOMES AMONG 3 PATIENTS
BACKGROUND: Chemotherapy may increase risk of SARS-COV-2 infection and COVID-19 severity. METHODS: A patient developed COVID-19 during chemotherapy for glioma. We retrospectively identified others diagnosed with COVID-19 during temozolomide or lomustine for glioma. RESULTS: (1) A 64 year-old woman (...
Autores principales: | Kim, Esther, Koshy, Amily, Higgins, Shannon, Lassman, Andrew, Iwamoto, Fabio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7650416/ http://dx.doi.org/10.1093/neuonc/noaa215.103 |
Ejemplares similares
-
COVD-22. COVID-19+ GLIOMA PATIENT CARE: LESSONS FROM A 5-PATIENT CASE SERIES
por: Daher, Ahmad
Publicado: (2020) -
COVD-29. CONTINUATION OF TEMOZOLOMIDE CHEMOTHERAPY IN A GLIOBLASTOMA PATIENT AFTER RESOLUTION OF COVID-19 PNEUMONIA
por: Thakkar, Jigisha, et al.
Publicado: (2020) -
COVD-18. POTENTIAL TO HARNESS SARS-COV-2 NEUROTROPISM IN THE DELIVERY OF ONCOLYTIC VIROTHERAPY FOR THE TREATMENT OF HIGH-GRADE GLIOMA
por: Immidisetti, Amanda, et al.
Publicado: (2020) -
COVD-27. THE COVID-19 PANDEMIC AND NEURO-ONCOLOGICAL PATIENTS
por: Norman, Sofya, et al.
Publicado: (2020) -
COVD-06. BRAIN TUMOURS AND COVID-19: THE PATIENT AND CAREGIVER EXPERIENCE
por: Voisin, Mathew, et al.
Publicado: (2020)